NewEdge Advisors’s Sotera Health SHC Stock Holding History

NewEdge Advisors’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-117	Closed	-$975	–	4038
2022 Q4	$975	Buy	+117	New	+$873	﹤0.01%	3039

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

NewEdge Advisors's SHC Position: Q1 2023 in Review

NewEdge Advisors sold out of Sotera Health (SHC) in Q1 2023, closing a stake of 117 shares — an estimated $975 sold.

NewEdge Advisors first reported a position in SHC in Q4 2022 and held it in 1 quarter. The position peaked at $975 in Q4 2022. 182 funds tracked by Wall St. Rank hold SHC as of Q1 2023.

NewEdge Advisors reported no remaining Sotera Health position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 117 Sotera Health shares in Q1 2023, an estimated $975.
NewEdge Advisors first reported a position in Sotera Health in Q4 2022 and held it in 1 quarter.
NewEdge Advisors's Sotera Health position peaked at $975 in Q4 2022.
182 funds tracked by Wall St. Rank held Sotera Health as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.